PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting

PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting

Bibliographic Details
Main Authors:	Myerson Jacob W, Allen John S, Williams Todd A, He Li, Tollefsen Douglas M, Lanza Gregory, Caruthers Shelton D, Wickline Samuel A
Format:	Article
Language:	English
Published:	Elsevier 2012-02-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing
by: Suruchi Hasija, et al.
Published: (2017-01-01)

Multi-resolution simultaneous 19F/1H 3D radial imaging for self-navigated respiratory motion-corrected and quantitative imaging
by: Lanza Gregory M, et al.
Published: (2010-01-01)

Quantitative cardiovascular magnetic resonance for molecular imaging
by: Lanza Gregory M, et al.
Published: (2010-11-01)

Thrombin inhibitor perfluorocarbon nanoparticles for treatment and 19F tracking of acute thrombosis
by: Wickline Samuel A, et al.
Published: (2010-01-01)

<it>In Vivo</it> quantitative imaging of angiogenesis-targeted PFOB nanoparticles in a hypercholesterol rabbit model using <sup>19</sup>F-MRI with ultra-short echo time balanced SSFP
by: Goette Matthew J, et al.
Published: (2012-02-01)

Cardiovascular MR function and coronaries: CMR 15 minute express
by: Watkins Mary P, et al.
Published: (2013-01-01)

Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
by: Anne H. Schmieder, et al.
Published: (2015-12-01)

Quantitative molecular imaging of angiogenesis-targeted fluorinated nanoparticles: new approaches for B<sub>1</sub>-mapping compensation for <sup>19</sup>F-MRI
by: Goette Matthew J, et al.
Published: (2013-01-01)

CION v2.0: a better way to T1 enhancement with iron oxides
by: Wickline Samuel A, et al.
Published: (2010-01-01)

Bivalirudin in percutaneous coronary intervention
by: Sam J Lehman, et al.
Published: (2006-12-01)

EXPERT CONSENSUS. THE CURRENT POSITION ON BIVALIRUDIN
by: статья Редакционная
Published: (2015-02-01)

Is it time to switch to bivalirudin for ECMO anticoagulation?
by: Amir Navaei, et al.
Published: (2023-08-01)

Regional expression of myocardial sheet dysfunction in dystrophin-deficient cardiomyopathy elucidated with diffusion tensor MRI and optical calcium mapping
by: Cheng Ya-Jian, et al.
Published: (2012-02-01)

Use of Bivalirudin for Anticoagulation in Interventional Cardiovascular Procedures
by: Zhen Ge, et al.
Published: (2018-06-01)

Bivalirudin resistance during heart transplantation surgery.
by: Tomasz Urbanowicz, et al.
Published: (2021-03-01)

Selection of an aptamer antidote to the anticoagulant drug bivalirudin.
by: Jennifer A Martin, et al.
Published: (2013-01-01)

19F MRS assessment of siRNA delivery to vascular cells via perfluorocarbon nanoparticles
by: Wickline Samuel A, et al.
Published: (2010-01-01)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
by: Emre Boysan, et al.
Published: (2023-09-01)

Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI
by: Wang Kezheng, et al.
Published: (2012-02-01)

Bivalirudin in Primary PCI: Can Its Glory Being Restored?
by: Yang Li, et al.
Published: (2021-09-01)

Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity.
by: Xavier Stephenne, et al.
Published: (2012-01-01)

Copper nanocolloids: a new thrombus molecular imaging approach to ruptured plaque
by: Pan Dipanjan, et al.
Published: (2012-02-01)

Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.
by: Huiying Zhang, et al.
Published: (2011-01-01)

Discovery of Heparin Mimetic, Potent, and Selective Inhibitors of Human Clotting Factor XIIIa
by: Kayla T. Vu, et al.
Published: (2024-07-01)

Antithrombotic therapy in chronic liver disease: to clot or not to clot
by: Peter Calvert, et al.
Published: (2021-11-01)

Bivalirudin-hydrogel coatings of polyvinyl chloride on extracorporeal membrane oxygenation for anticoagulation
by: Wenqing Gao, et al.
Published: (2023-12-01)

Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.
by: Navin K Kapur, et al.
Published: (2012-01-01)

Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
by: Ravi K Ramana, et al.
Published: (2008-06-01)

Efficacy and safety of bivalirudin in percutaneous coronary intervention for coronary bifurcation lesions
by: XIANG Chaojun, et al.
Published: (2019-11-01)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
by: Abdul Mannan Khan Minhas, et al.
Published: (2017-01-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

To clot, or not to clot – Antithrombotic therapy is the question
by: E. Osuch, et al.
Published: (2019-07-01)

Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
by: Guiping Wang, et al.
Published: (2024-01-01)

Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance
by: Yizhi Zhang, et al.
Published: (2024-02-01)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

The Proteome Content of Blood Clots Observed Under Different Conditions: Successful Role in Predicting Clot Amyloid(ogenicity)
by: Douglas B. Kell, et al.
Published: (2025-02-01)

Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays
by: Ivan D. Tarandovskiy, et al.
Published: (2024-04-01)

Dependence of clot structure and fibrinolysis on apixaban and clotting activator
by: Rebecca A. Risman, et al.
Published: (2024-11-01)

Association of clot ultrastructure with clot perviousness in stroke patients
by: Young Dae Kim, et al.
Published: (2023-09-01)

What Looks Like a Clot But Is Not a Clot?
by: Orly Leiva, MD, et al.
Published: (2020-10-01)